An overview of the clinical use of ondansetron in preschool age children
Authors Ira Todd Cohen
Published 15 May 2007 Volume 2007:3(2) Pages 333—339
Ira Todd Cohen
Department of Anesthesiology, Children’s National Medical Center, George Washington University, Washington, DC, USA
Abstract: The introduction of 5-HT3 receptor antagonist has revolutionized the prevention and treatment of nausea and vomiting in preschool aged children. These distressing symptoms, arising from multiple etiologies such as anesthesia, chemotherapy, and viral infection, are a major concern of patients and their families. Clinical research has demonstrated the antiemetic effectiveness of ondansetron in children. Although most of these studies focus primarily on preventing vomiting across the pediatric age group, they provide strong evidence for the use of ondansetron in preschool age children. For children at high risk, pediatric practice guidelines recommend ondansetron in conjunction with other antiemetics to achieve complete control of symptoms.
Keywords: ondansetron, children, preschool, nausea, vomiting, postoperative nausea and vomiting, chemotherapy, gastroenteritis